Application | Comment | Organism |
---|---|---|
medicine | development of dopamine treatment ainst Parkinson's disease, drug target for treatment of neurodgenerative diseases | Sus scrofa |
Cloned (Comment) | Organism |
---|---|
- |
Sus scrofa |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
L-tryptophan | Sus scrofa | - |
tryptamine + CO2 | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Sus scrofa | - |
pig | - |
Source Tissue | Comment | Organism | Textmining |
---|
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
5-hydroxy-L-tryptophan | - |
Sus scrofa | serotonin + CO2 | - |
? | |
5-hydroxytryptamine + O2 | side reaction, decarboxylation-dependent transamination | Sus scrofa | 5-hydroxyindolacetaldehyde + NH3 | - |
? | |
alpha-methyl-dopamine + O2 | side reaction, decarboxylation-dependent transamination | Sus scrofa | 3,4-dihydroxyphenylacetone + NH3 | - |
? | |
alpha-methyl-L-Dopa | - |
Sus scrofa | alpha-methyl-dopamine + CO2 | - |
? | |
dopamine + O2 | - |
Sus scrofa | 3,4-dihydroxyphenylacetaldehyde + NH3 | - |
? | |
L-Dopa | - |
Sus scrofa | dopamine + CO2 | - |
? | |
L-tryptophan | - |
Sus scrofa | tryptamine + CO2 | - |
? | |
additional information | exhibits half-transaminase activity toward D-aromatic amino acids and oxidative deaminase activity toward aromatic amines | Sus scrofa | ? | - |
? |
Subunits | Comment | Organism |
---|---|---|
homodimer | - |
Sus scrofa |
Synonyms | Comment | Organism |
---|---|---|
DDC | - |
Sus scrofa |
DOPA decarboxylase | - |
Sus scrofa |
Cofactor | Comment | Organism | Structure |
---|---|---|---|
pyridoxal 5'-phosphate | - |
Sus scrofa |